Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

(2019) Raziye Piranlioglu et al.   Nature Communications

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

(2019) Tessa P. Sandberg et al.   BMC CANCER

Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade

(2019) DAIKO WAKITA et al.   ANTICANCER RESEARCH

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

(2019) Leonie Voorwerk et al.   NATURE MEDICINE

Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling

(2019) Xingbo Long et al.   Cell Death & Disease

Current Landscape of Immunotherapy in Breast Cancer

(2019) Sylvia Adams et al.   JAMA Oncology

Versican and Tumor-Associated Macrophages Promotes Tumor Progression and Metastasis in Canine and Murine Models of Breast Carcinoma

(2019) Diego Carlos dos Reis et al.   Frontiers in Oncology

Breast cancer

(2019) Nadia Harbeck et al.   Nature Reviews Disease Primers

Single Cell Mass Cytometry of Non-Small Cell Lung Cancer Cells Reveals Complexity of In vivo And Three-Dimensional Models over the Petri-dish

(2019) Alföldi et al.   Cells

Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-b ]pyrazole-7-carboxamides

(2018) András Demjén et al.   ARCHIV DER PHARMAZIE

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment

(2018) Suzanne Ostrand-Rosenberg et al.   JOURNAL OF IMMUNOLOGY

Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas

(2018) Xiujuan Li et al.   Oncotarget

FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors

(2018) Viviana Cremasco et al.   Cancer Immunology Research

Roles of the immune system in cancer: from tumor initiation to metastatic progression

(2018) Hugo Gonzalez et al.   GENES & DEVELOPMENT

Imidazo[1,2-b]pyrazole-7-carboxamides Induce Apoptosis in Human Leukemia Cells at Nanomolar Concentrations

(2018) Gábor Szebeni et al.   MOLECULES

Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles

(2018) Shannon Grabosch et al.   ONCOGENE

Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters

(2017) Gabor J. Szebeni et al.   MEDIATORS OF INFLAMMATION

Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade

(2017) Maria Ouzounova et al.   Nature Communications

CD11b+Gr-1dim Tolerogenic Dendritic Cell-Like Cells Are Expanded in Interstitial Lung Disease in SKG Mice

(2017) Sho Sendo et al.   Arthritis & Rheumatology

RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis

(2015) Laura Strauss et al.   CANCER CELL

FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data

(2015) Sofie Van Gassen et al.   CYTOMETRY PART A

The expanding family of regulatory B cells

(2015) Claudia Mauri et al.   INTERNATIONAL IMMUNOLOGY

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer

(2015) Hiroshi Katoh et al.   MEDIATORS OF INFLAMMATION

Novel real-time cell analysis platform for the dynamic monitoring of ionizing radiation effects on human tumor cell lines and primary fibroblasts

(2015) IMOLA MÁN et al.   Molecular Medicine Reports

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy

(2015) Kelly Kersten et al.   Frontiers in Immunology

Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence

(2014) A. R. de Biasi et al.   CLINICAL CANCER RESEARCH

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Gr-1dimCD11b+ Immature Myeloid-Derived Suppressor Cells but Not Neutrophils Are Markers of Lethal Tuberculosis Infection in Mice

(2014) E. N. Tsiganov et al.   JOURNAL OF IMMUNOLOGY

Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

(2014) K. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

(2014) Elizabeth J. Hamson et al.   Proteomics Clinical Applications

Effect of bortezomib in combination with cisplatin and 5-fluorouracil on 4T1 breast cancer cells

(2013) AZMI YERLIKAYA et al.   Molecular Medicine Reports

viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia

(2013) El-ad David Amir et al.   NATURE BIOTECHNOLOGY

Fibroblast activation protein

(2012) Rui Liu et al.   CANCER BIOLOGY & THERAPY

Identification of Galectin-1 as a Critical Factor in Function of Mouse Mesenchymal Stromal Cell-Mediated Tumor Promotion

(2012) Gábor János Szebeni et al.   PLoS One

Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections

(2012) Takayuki Matsumura et al.   Nature Communications

Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen

(2012) Stefano Ugel et al.   Cell Reports

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

A cell-microelectronic sensing technique for the screening of cytoprotective compounds

(2010) Puskás   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

(2010) Abhimanyu S. Paraskar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Breast Cancer Before Age 40 Years

(2009) Carey K. Anders et al.   SEMINARS IN ONCOLOGY

Imagable 4T1 model for the study of late stage breast cancer

(2008) Kai Tao et al.   BMC CANCER

CANCER BIOLOGY: All in the Stroma: Cancer's Cosa Nostra

(2008) J. Marx   SCIENCE